All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
KCE Reports 306 (2019) A healthy lifestyle remains the most effective way of avoiding cardiovascular diseases and their consequences. Yet since 2002, the annual number of people who use cholesterol-lowering drugs from the statin family increased from 400,000 to 1,500,000. Currently, 25% of the population aged 40 and above take these drugs. Despite decreases in price due to the fact that all statins now exist in generic form, their total cost still stands at 160 million euros annually.
KCE Reports 314 (2019) Under the insurance Law of 4 April 2014 a “monitoring office for insurance premiums’ was established. Its mission is to examine proposals for premium supplements or refusals by insurances that guarantee the repayment of the capital of a credit (Art. 217). Article 218 of this law provides that KCE conducts a study to assess whether the premiums charged by the insurers are in line with the evolution of medical techniques and health care, with regard to the main pathologies concerned.
Asylum seekers in Belgium: options for a more equitable access to health care. A stakeholder consultation
KCE Reports 319 (2019, 2ed.)